Stock listing

SIX Swiss:KURN Kuros Biosciences Ltd. Aktie

Home listing (SIX Swiss) of Kuros Biosciences Ltd.

Follow Kuros Biosciences Ltd. into a list and get an email when it puts out news.

Share price · SIX:KURN

16.85 CHF -1.64 (-8.9%)

Close on Oct 19, 2026

Past 3 months -12.7% · daily closes, Jul 6, 2026 – Oct 19, 2026, adjusted for splits
Day range
16.52 – 17.18 CHFOct 19, 2026
Volume
366,274 sharesOct 19, 2026
Market cap
607.4M CHFAt the close on Oct 19, 2026 · price × 36.05M shares outstanding
Kuros Biosciences Ltd. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
SIX Swiss:KURN · Home16.85 CHF-1.64 (-8.9%)366,27417.1617.1816.5218.49Close on Oct 19, 2026
LSE:0RHR16.87 CHF+0.10 (+0.6%)83,18616.7817.1016.5116.77Close on Oct 19, 2026

Daily closes

Last 3 months, Jul 20, 2026 – Oct 19, 2026 · SIX:KURN · CHF, adjusted for splits

DayCloseChange%OpenHighLowVolume
16.85-1.64-8.9%17.1617.1816.52366,274
18.49-0.30-1.6%20.0020.7418.07641,526
18.79+0.74+4.1%18.3918.8217.96123,324
18.05-0.73-3.9%18.7018.9017.95122,059
18.78+0.43+2.3%18.5018.9018.28130,284
18.35+0.35+1.9%18.3218.6017.94146,035
18.00-0.20-1.1%18.0018.4917.15140,804
18.20-0.87-4.6%18.9618.9617.95167,491
19.07+0.66+3.6%18.4019.0718.10254,740
18.41-0.22-1.2%18.5419.1718.26110,532
18.63-0.22-1.2%18.8519.6218.42250,793
18.85+0.56+3.1%18.5019.1017.98371,222
18.29+0.36+2.0%18.0018.6117.89221,517
17.93+0.68+3.9%17.3018.1117.23141,976
17.25-0.36-2.0%17.4817.8017.07158,401
17.61+0.43+2.5%17.3917.8117.01159,190
17.18-0.38-2.2%17.3017.4717.02164,926
17.56-0.04-0.2%17.7018.1917.40189,229
17.60+0.67+4.0%17.0017.7716.85190,943
16.93+0.47+2.9%17.0017.2116.61165,316
16.46-0.85-4.9%17.4417.7616.46400,393
17.31+0.35+2.1%17.1217.4517.0194,133
16.96+0.08+0.5%16.9017.2016.76147,309
16.88-0.96-5.4%17.7917.8216.88278,443
17.84-0.38-2.1%18.0518.3517.65104,967
18.22-0.42-2.3%18.7618.7918.10185,114
18.64-0.18-1.0%18.9919.4818.58170,708
18.82-0.45-2.3%19.0019.2218.55139,009
19.27+0.68+3.7%18.5019.4318.23220,272
18.59+0.86+4.9%17.5018.5917.20440,128
17.73-0.34-1.9%18.1618.1617.54331,958
18.07-0.45-2.4%18.5018.6717.82348,342
18.52-0.38-2.0%18.6519.2618.52298,051
18.90-0.70-3.6%19.7019.7418.83435,276
19.60-1.56-7.4%21.0021.0019.52354,352
21.16-0.52-2.4%21.7221.9021.0088,809
21.68+0.44+2.1%21.2421.7021.16131,856
21.24-0.18-0.8%21.4021.7021.18127,228
21.42+0.26+1.2%21.4221.8821.24155,981
21.16-0.36-1.7%21.4221.4620.74158,881
21.52-0.94-4.2%22.1822.1821.52322,359
22.46-0.14-0.6%22.8623.9022.46230,831
22.60+0.84+3.9%21.7222.9821.70237,517
21.76+0.36+1.7%21.5022.3221.28173,967
21.40-0.50-2.3%21.8821.9621.32160,253
21.90-1.24-5.4%23.1223.3021.30474,542
23.14+0.14+0.6%23.4023.8422.50360,953
23.00-0.06-0.3%23.0823.4022.62154,371
23.06+0.66+2.9%22.4223.4622.30126,741
22.40-0.66-2.9%23.3623.5622.40146,103
23.06+0.02+0.1%23.0023.4822.90116,593
23.04-0.36-1.5%23.4023.8623.04134,699
23.40+0.44+1.9%23.1223.6023.02123,891
22.96+0.46+2.0%22.5823.6622.40165,680
22.50-0.16-0.7%22.8023.1422.02157,756
22.66-0.88-3.7%23.7223.7222.60165,608
23.540.000.0%23.2623.6222.66211,412
23.54+3.06+14.9%22.4824.5022.42651,523
20.48+0.06+0.3%20.3020.8020.10104,310
20.42+0.62+3.1%20.1420.6819.94158,944
19.80-0.56-2.8%20.4620.4619.40141,416
20.36-0.04-0.2%20.4220.9819.90125,767
20.40+0.48+2.4%19.9520.8019.95172,610
19.92+0.39+2.0%19.3020.1019.2290,087
19.53-1.21-5.8%20.7220.9019.27151,823
Ticker
SIX Swiss:KURN
Asset type
Stock
Exchange
SIX Swiss
Currency
CHF

What changed lately

Latest news

Kuros Biosciences increases 2026 annual guidance, The company reports 40% year-over-year increase in sales in the first nine months of 2026

Oct 15, 2026

Closed 18.49 (-1.6%) on Oct 15, 2026

Kuros Biosciences delivers 45% H1 2026 year-over-year sales growth and increases overall profitability

Aug 13, 2026

Closed 23.14 (+0.6%) on Aug 13, 2026

Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadership for next phase of growth

May 7, 2026

Kuros Biosciences reports 51% year-over-year increase in sales in the first three months of 2026

Apr 14, 2026

Kuros Biosciences delivers 72% year-over-year sales growth, reaching USD 146.1 million for 2025

Mar 10, 2026

Kuros Biosciences to provide investor update at Octavian and Baader Bank Conferences

Jan 13, 2026

Kuros Biosciences announces enrollment of first patient in ASTRA study – A global, prospective, randomized, multi-center clinical trial in foot and ankle fusion

Dec 2, 2025

Kuros Biosciences to present at the Piper Sandler 37th Annual Healthcare Conference

Nov 26, 2025

Kuros Biosciences increases the annual guidance for 2025, The company reports 77% year-over-year increase for the first nine months of 2025

Oct 16, 2025

Kuros Biosciences debuts commercial launch of MagnetOs MIS Delivery System at SMISS 2025

Sep 30, 2025

All Kuros Biosciences Ltd. news

Decks

Kuros Biosciences Ltd. on 6ix

News releases
8 in the last 12 months · 18 in all · newest Oct 15, 2026 · oldest 2025
Decks
9 decks · latest September 2026

Where Kuros Biosciences Ltd. is listed

ListingExchangeCountryCurrency
SIX Swiss:KURN · Home listing · This pageSIX SwissSwitzerlandCHF
BX Swiss:YTSNBX SwissSwitzerlandCHF
LSE:0RHRLSEUnited KingdomCHF
OTC:CSBTFOTCUnited StatesUSD
Dusseldorf:YTSNDusseldorfGermanyEUR
gettex:YTSNgettexGermanyEUR
LS Exchange:A2ALS5LS ExchangeGermanyEUR
Lang & Schwarz:A2ALS5Lang & SchwarzGermanyEUR
Aquis:KURNZAquisUnited KingdomCHF
Frankfurt:YTSNFrankfurtGermanyEUR
Munich:YTSNMunichGermanyEUR
Stuttgart:YTSNStuttgartGermanyEUR
Tradegate:YTSNTradegateGermanyEUR
Turquoise:KURNZTurquoiseUnited KingdomCHF

Log in to ask 6ix AI your own questions about Kuros Biosciences Ltd.